Patient 1 also showed higher levels of PTEN (phosphatase and tensin homolog), AKT1, and Ki67. Patient 2 showed an increased STAT3 (signaling transducer and activator of transcription 3) (Figure 2C), likely due to the primary tumor difference or adaptation to the treatment. This evidence concerns the gene STAT3 and neoplasm.